On the eve of a trial with a former employee turned whistleblower, biotechnology company Biogen agreed to pay $900 million to settle allegations of lavishly overpaying doctors to prescribe their drugs to Multiple Sclerosis patients.

Welcome • User Guide
ToS • Privacy • Canary
Donate • Bugs • License

©2025 Poal.co

968

•

On the eve of a trial with a former employee turned whistleblower, biotechnology company Biogen agreed to pay $900 million to settle allegations of lavishly overpaying doctors to prescribe their drugs to Multiple Sclerosis patients. (www.natlawreview.com)

(post is archived)

You are currently inside a comment thread.

Click here to see all the comments (4).

[–] • 1 pt

If you can really cure it with Selenium I might change my mind but otherwise these poor people should have a choice to get a Biogen "therapy" to end their misery.

link